MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Health-focused software CancerAid has entered the United States market after closing deals that will link its thousands of users to the database of renowned Los Angeles hospital Cedars-Sinai and the services offered by tech giant Apple.
CancerAid serves as a digital tool for cancer patients to keep track of the symptoms they experience on a daily basis. The app also provides support by collecting a wide array of educational resources about cancer and keeping users' medical history records. CancerAid users can also join an online community with other patients who use the app and receive notifications on the latest news about cancer research.
According to reports, CancerAid will provide comprehensive services to its users now that it has established a partnership with Epic Systems, the electronic medical record system that provides services to Cedars-Sinai.
The partnership between CancerAid and Cedars-Sinai means that cancer patients who use the app can immediately share the data they enter into the app and onto their doctors’ database.
“Integrating into the healthcare providers’ workflow is crucial when you’re trying to improve clinical practice in digital health. … Integrating into a large health system can be difficult and our product team have done a wonderful job of navigating those challenges,” CancerAid CTO Andrew Harvey said in a statement (via Healthcare IT).
CancerAid co-founder Nikhil Pooviah told TechCrunch in an email statement, “Patients will be able to use the patient-facing app at home, with a feedback loop back to their care team (physicians, nurses) in the hospital in real-time. This feedback loop helps reduce [emergency room] visits and 30-day readmissions (saving $19,000 per patient per year).”
Meanwhile, CancerAid’s partnership with Apple will be manifested through wearable devices like the Apple Watch, according to TechCrunch.
Right now, CancerAid’s regular app users are reportedly about 20,000.
